Literature DB >> 9917323

Chemical modification and site-directed mutagenesis of methionine residues in recombinant human granulocyte colony-stimulating factor: effect on stability and biological activity.

H S Lu1, P R Fausset, L O Narhi, T Horan, K Shinagawa, G Shimamoto, T C Boone.   

Abstract

Chemical modification and mutagenesis of methionines in recombinant human granulocyte colony-stimulating factor (G-CSF) were investigated. Selective oxidation of G-CSF by H2O2 and t-butyl hydroperoxide leads to generation of different oxidized forms. Four modified forms were isolated and shown to contain 1 to 4 oxidized methionyl residues. All methionines in G-CSF are reactive, with reaction kinetics following the order of Met1>Met138>Met127>>>Met122. H2O2 oxidation of Met122 is relatively slow and is biphasic with a faster second reaction phase being affected by the oxidation of Met127. All oxidized forms retain gross G-CSF conformation similar to that of the native molecule and are able to bind the soluble G-CSF receptor. However, G-CSF form oxidized at both Met127 and Met122 is unstable and exhibits decreased ability to dimerize the receptor after exposure to acid or elevated temperature. All modified forms, except Met1-oxidized G-CSF, also show significantly lower biological activity. Our data suggest that Met138 is solvent accessible and its surrounding microenvironment may be critical for G-CSF function, whereas Met127 is less accessible to solvent and Met122 is near the hydrophobic core. Oxidation at both Met127 and Met122 results in alterations of G-CSF structure that affect the apparent molecular size, polarity, and stability and lead to the loss of G-CSF biological function. G-CSF variants with Leu replacement at Met127 or at Met138 are not completely resistant to oxidation-induced inactivation, while the variant with Leu replacement at both sites is more stable and can retain in vitro biological activity following oxidation. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9917323     DOI: 10.1006/abbi.1998.1022

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  18 in total

1.  Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor.

Authors:  Eva Y Chi; Sampathkumar Krishnan; Brent S Kendrick; Byeong S Chang; John F Carpenter; Theodore W Randolph
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

2.  Distinct oxidative cleavage and modification of bovine [Cu- Zn]-SOD by an ascorbic acid/Cu(II) system: Identification of novel copper binding site on SOD molecule.

Authors:  Hiroshi Uehara; Shen Luo; Baikuntha Aryal; Rodney L Levine; V Ashutosh Rao
Journal:  Free Radic Biol Med       Date:  2016-02-10       Impact factor: 7.376

Review 3.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

Review 4.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

5.  Mass spectrometric distinction of in-source and in-solution pyroglutamate and succinimide in proteins: a case study on rhG-CSF.

Authors:  Mukesh Kumar; Amarnath Chatterjee; Anand P Khedkar; Mutyalasetty Kusumanchi; Laxmi Adhikary
Journal:  J Am Soc Mass Spectrom       Date:  2013-01-03       Impact factor: 3.109

6.  Effects of excipients on the hydrogen peroxide-induced oxidation of methionine residues in granulocyte colony-stimulating factor.

Authors:  Jin Yin; Jhih-Wei Chu; Margaret Speed Ricci; David N Brems; Daniel I C Wang; Bernhardt L Trout
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

7.  Metal-mediated protein oxidation: applications of a modified ELISA-based carbonyl detection assay for complex proteins.

Authors:  Hiroshi Uehara; V Ashutosh Rao
Journal:  Pharm Res       Date:  2014-09-03       Impact factor: 4.200

8.  Determination of Critical Quality Attributes for a Biotherapeutic in the QbD Paradigm: GCSF as a Case Study.

Authors:  Sumit K Singh; Deepak Kumar; Anurag S Rathore
Journal:  AAPS J       Date:  2017-09-05       Impact factor: 4.009

9.  Method for Quantifying Oxidized Methionines and Application to HIV-1 Env.

Authors:  Joshua T Shipman; Eden P Go; Heather Desaire
Journal:  J Am Soc Mass Spectrom       Date:  2018-07-09       Impact factor: 3.109

10.  Modulation of protein aggregation by polyethylene glycol conjugation: GCSF as a case study.

Authors:  Rahul S Rajan; Tiansheng Li; Mohini Aras; Christopher Sloey; Weston Sutherland; Hiromi Arai; Robert Briddell; Olaf Kinstler; Alexis M K Lueras; Yu Zhang; Heather Yeghnazar; Michael Treuheit; David N Brems
Journal:  Protein Sci       Date:  2006-04-05       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.